A phase I/II study of mTOR inhibitor temsirolimus in patients with unresectable hepatocellular carcinoma (HCC)
Refereed conference paper presented and published in conference proceedings


Other information
All Author(s) ListYEO Winnie, CHAN Lam Stephen, MO Kwok Fai, HUI Pun Edwin, KOH Chun, LI Leung, HUI Joyce, CHU C M, LOONG Herbert Ho Fung, YU Simon
Name of ConferenceESMO 15th World Congress on GastroIntestinal Cancer
Start Date of Conference03/07/2013
Country/Region of ConferenceSpain
Proceedings TitleESMO 15th World Congress on GastroIntestinal Cancer
Detailed descriptionorganized by European Society for Medical Oncology,
Year2013
Month7
Place of PublicationSpain, Barcelona
LanguagesEnglish-United Kingdom
KeywordsmTOR; HCC

Last updated on 2018-19-01 at 00:20